Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

45.12
-0.2100-0.46%
Post-market: 45.370.2480+0.55%19:59 EDT
Volume:9.36M
Turnover:425.05M
Market Cap:199.57B
PE:11.27
High:46.16
Open:45.80
Low:45.07
Close:45.33
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.87
T/O Rate:0.29%
Dividend:1.72
Dividend Rate:3.82%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.13
PE(LYR):12.46

Loading ...

Sector Update: Healthcare Stocks Rise Thursday Afternoon

MT Newswires Live
·
Jun 12

Dow Jones Top Company Headlines at 1 PM ET: SpaceX IPO Draws at Least $5 Billion Order From BlackRock | Amazon ...

Dow Jones
·
Jun 12

Novo Nordisk Reports Cybersecurity Incident Involving IT System Access

MT Newswires Live
·
Jun 12

Novo Nordisk's Wegovy Pill Gains U.K. Approval, Its First in Europe -- Update

Dow Jones
·
Jun 12

Novo Nordisk hit by cyber incident, probes data breach

Bloomberg
·
Jun 11

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle

Reuters
·
Jun 11

Novo Nordisk announces security incident on ‘limited number’ of systems

TIPRANKS
·
Jun 11

Novo Nordisk reports Wegovy pill approved in UK

TIPRANKS
·
Jun 11

Novo Nordisk Has Clear Lead in Oral Weight-Loss Market -- Market Talk

Dow Jones
·
Jun 11

Market Chatter: Employers to Drop Coverage for Weight-loss Drugs

MT Newswires Live
·
Jun 11

Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jun 11

Europe's Big Pharma Could Win Investors' Favor With Busy End of Year -- Market Talk

Dow Jones
·
Jun 10

Movement Alert|Novo Nordisk Rises 3.15% in Regular Trading, ADA Clinical Data and Oral Wegovy Prescriptions Surpassing 3 Million Drive Gains

Market Focus
·
Jun 10

Novo Nordisk faces off in court with South African weight-loss drug compounder

Reuters
·
Jun 10

Assessing Novo Nordisk (NYSE:NVO) Valuation After Recent Share Weakness And GLP‑1 Growth Questions

Simply Wall St.
·
Jun 10

Movement Alert|Novo Nordisk Rises 3.13% in Regular Trading, Oral Wegovy Prescriptions Surpass 3 Million Amid ADA Conference Catalysts

Market Focus
·
Jun 10

FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats up

Reuters
·
Jun 09

AI Bulls Are Back in the Driving Seat as Stock Market Sidelines Bubble Fears -- Barrons.com

Dow Jones
·
Jun 09

Bellevue says obesity, diabetes drug market shifts focus to patient adherence at ADA 2026

Reuters
·
Jun 09

Use of GLP-1 drugs early in pregnancy should not cause alarm

Reuters
·
Jun 09